• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH URINARY/CEREBROSPINAL FLUID PROTEIN (UCFP); BIURET (COLORIMETRIC), TOTAL PROTEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH URINARY/CEREBROSPINAL FLUID PROTEIN (UCFP); BIURET (COLORIMETRIC), TOTAL PROTEIN Back to Search Results
Model Number N/A
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/11/2024
Type of Reportable Event Malfunction
Event or Problem Description
The customer reported a discordant depressed urinary/cerebrospinal fluid protein (ucfp) result was obtained on a patient sample on an atellica ch 930 instrument.The discordant result was reported to the physician(s), who questioned the result.The sample was repeated on an alternate atellica ch 930 instrument.The repeat result was the same as the discordant result.The patient sample was repeated on an alternate non-siemens method at an alternate site and the result was higher.The customer is not sure which result is correct and sent both results to the physician without issuing a corrected report.There are no known reports of patient intervention or adverse health consequences due to the discordant depressed ucfp result.
 
Additional Manufacturer Narrative
A united states customer contacted the siemens healthcare diagnostics remote services center (rsc) regarding a discordant depressed urinary/cerebrospinal fluid protein (ucfp) result obtained on a patient sample on an atellica ch 930 instrument.The customer stated that the ucfp quality control was in range on both atellica ch analyzers.Siemens healthcare diagnostics is investigating.
 
Additional Manufacturer Narrative
Additional information (06-may-2024): the patient sample is not available for further testing or investigation by siemens.Based on the available information, the cause of the discordant result is sample specific.No medical device issue identified.In section h6, the investigation finding and investigation conclusion codes were updated.Initial mdr 2432235-2024-00087 was filed on 02-may-2024.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA CH URINARY/CEREBROSPINAL FLUID PROTEIN (UCFP)
Common Device Name
BIURET (COLORIMETRIC), TOTAL PROTEIN
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
500 gbc drive po box 6101
registration # 2517506
newark DE 19714 6101
Manufacturer Contact
eiman sulieman
500 gbc drive
po box 6101
newark, DE 19714-6101
7372808688
MDR Report Key19232474
Report Number2432235-2024-00087
Device Sequence Number6834317
Product Code CEK
UDI-Device Identifier00630414279206
UDI-Public00630414279206
Combination Product (Y/N)N
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/04/2024
Device Model NumberN/A
Device Catalogue Number11097543
Device Lot Number130273
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/15/2024
Supplement Date Received by Manufacturer05/06/2024
Initial Report FDA Received Date05/02/2024
Supplement Report FDA Received Date06/04/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured07/05/2023
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age30 YR
Patient SexFemale
-
-